Skip to main content
SPARC AI INC. logo

SPARC AI INC. — Investor Relations & Filings

Ticker · SPAI ISIN · CA8465011044 LEI · 984500BCA778DEC1D917 CSE Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 297 across all filing types
Latest filing 2026-05-06 Regulatory Filings
Country CA Canada
Listing CSE SPAI

About SPARC AI INC.

https://sparcai.co/

SPARC AI INC. is a software and electronics engineering company specializing in geospatial technology and AI-driven solutions for GPS-denied environments. The company develops proprietary algorithms and patented processes to deliver precision target acquisition and autonomous navigation capabilities for drones, robotic systems, and edge devices. Its core offering is a zero-signature, sensor-independent system that provides real-time geolocation and situational awareness without reliance on GPS, satellite, internet, radar, or external data feeds. This technology, including the Overwatch intelligent interface, is purpose-built for Denied, Degraded, Intermittent, and Limited (DDIL) operational environments, empowering defense, rescue, first responders, and commercial organizations to maintain operational security and effectiveness in contested areas.

Recent filings

Filing Released Lang Actions
Notice of the meeting and record date - English.pdf
Regulatory Filings
2026-05-06 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings
2026-05-01 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings
2026-05-01 English
Audited annual financial statements – English.pdf
Regulatory Filings
2026-05-01 English
Material change report - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a Canadian Form 51-102F3 Material Change Report describing the closing of an upsized non-brokered private placement (1,714,286 units for gross proceeds of $2.4 million), including details of shares, warrants, insider participation, and use of proceeds. This is an update on the company’s fundraising/financing activity, fitting the definition of a Capital/Financing Update (CAP).
2026-04-10 English
Material change report - English.pdf
Regulatory Filings Classification · 83% confidence The document is a corporate press release providing an update on Sharp Therapeutics’ R&D pipeline programs, discussing advancement of alternative compounds and platform programs. It does not present financial results (ER/IR), detailed investor slides (IP), or specific financing activity (CAP), nor is it a regulatory-required form (10-K, IR) or vote result (DVA). This general corporate announcement falls under the fallback category ‘Regulatory Filings (RNS)’.
2026-04-10 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.